ATE518522T1 - Farbstofffreie pharmazeutische suspensionen enthaltend acetaminophen - Google Patents

Farbstofffreie pharmazeutische suspensionen enthaltend acetaminophen

Info

Publication number
ATE518522T1
ATE518522T1 AT05818055T AT05818055T ATE518522T1 AT E518522 T1 ATE518522 T1 AT E518522T1 AT 05818055 T AT05818055 T AT 05818055T AT 05818055 T AT05818055 T AT 05818055T AT E518522 T1 ATE518522 T1 AT E518522T1
Authority
AT
Austria
Prior art keywords
dye
suspensions containing
free pharmaceutical
pharmaceutical suspensions
containing acetaminophen
Prior art date
Application number
AT05818055T
Other languages
English (en)
Inventor
Gail Buehler
Original Assignee
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc
Application granted granted Critical
Publication of ATE518522T1 publication Critical patent/ATE518522T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT05818055T 2004-10-29 2005-10-27 Farbstofffreie pharmazeutische suspensionen enthaltend acetaminophen ATE518522T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/978,035 US20060093631A1 (en) 2004-10-29 2004-10-29 Dye-free pharmaceutical suspensions and related methods
PCT/US2005/039348 WO2006050302A2 (en) 2004-10-29 2005-10-27 Dye-free pharmaceutical suspensions and related methods

Publications (1)

Publication Number Publication Date
ATE518522T1 true ATE518522T1 (de) 2011-08-15

Family

ID=35712029

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05818055T ATE518522T1 (de) 2004-10-29 2005-10-27 Farbstofffreie pharmazeutische suspensionen enthaltend acetaminophen

Country Status (14)

Country Link
US (1) US20060093631A1 (de)
EP (1) EP1809241B1 (de)
JP (1) JP2008518948A (de)
KR (1) KR101317657B1 (de)
CN (1) CN101068530A (de)
AR (1) AR051411A1 (de)
AT (1) ATE518522T1 (de)
BR (1) BRPI0517245A (de)
CA (1) CA2585852C (de)
ES (1) ES2368249T3 (de)
MX (1) MX2007005207A (de)
PL (1) PL1809241T3 (de)
RU (1) RU2395275C2 (de)
WO (1) WO2006050302A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7201920B2 (en) 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
US20080014275A1 (en) * 2006-07-13 2008-01-17 Buehler Gail K Pharmaceutical suspensions and related methods
JP5301468B2 (ja) * 2008-01-18 2013-09-25 旭化成ファーマ株式会社 安定な医薬組成物
WO2011041414A1 (en) 2009-09-30 2011-04-07 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse
WO2014085599A1 (en) 2012-11-30 2014-06-05 Acura Pharmaceuticals, Inc. Self-regulated release of active pharmaceutical ingredient
US9642811B2 (en) 2014-03-26 2017-05-09 Sun Pharma Advanced Research Company Ltd. Abuse deterrent immediate release biphasic matrix solid dosage form
US11103581B2 (en) 2015-08-31 2021-08-31 Acura Pharmaceuticals, Inc. Methods and compositions for self-regulated release of active pharmaceutical ingredient
GB2571937B (en) * 2018-03-12 2021-07-14 Syri Ltd Stable liquid suspension composition of fludrocortisone
CN112274483A (zh) * 2020-10-28 2021-01-29 河北冀衡药业股份有限公司 一种对乙酰氨基酚混悬滴剂及其制备方法
CR20240566A (es) * 2023-01-20 2025-02-25 Opella Healthcare Group Sas Formulaciones de fexofenadina sin parabenos

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3485719A (en) * 1967-10-13 1969-12-23 Us Agriculture Continuous process for producing xanthomonas heteropolysaccharide
US4427681A (en) * 1982-09-16 1984-01-24 Richardson-Vicks, Inc. Thixotropic compositions easily convertible to pourable liquids
GB8317696D0 (en) * 1983-06-29 1983-08-03 Shell Int Research Preparing xanthomonas heteroplysaccharide
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
NZ234143A (en) * 1989-06-28 1991-10-25 Mcneil Ppc Inc Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents
US5112604A (en) * 1989-09-01 1992-05-12 Riker Laboratories, Inc. Oral suspension formulation
US5296241A (en) * 1991-04-03 1994-03-22 Brimberg Barnett J Therapeutic composition and method of using same for treatment of hangover
US5272137A (en) * 1992-02-14 1993-12-21 Mcneil-Pfc, Inc. Aqueous pharmaceutical suspension for pharmaceutical actives
EP0620001A1 (de) * 1993-04-16 1994-10-19 McNEIL-PPC, INC. Wässrige pharmazeutische Suspension und Verfahren zu ihrer Herstellung
AU7176994A (en) * 1993-06-25 1995-01-17 Ibah, Inc. Taste-masked acetaminophen suspensions and methods of making the same
CN1132070A (zh) * 1994-12-21 1996-10-02 麦克尼尔-Ppc公司 药用的水悬浮液制剂
US5948438A (en) * 1995-01-09 1999-09-07 Edward Mendell Co., Inc. Pharmaceutical formulations having improved disintegration and/or absorptivity
IT1286496B1 (it) * 1996-11-20 1998-07-15 Leetrim Ltd Dublin Composizione farmaceutica orale ad attivita' antipiretica,analgesica ed antiinfiammatoria
US5759579A (en) * 1996-12-05 1998-06-02 American Home Products Corporation Pharmaceutical suspension systems
US6132758A (en) * 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
US6784326B1 (en) * 1998-06-17 2004-08-31 Cognis Corporation Process for improving stability of glycerin
US7101572B2 (en) * 2001-12-07 2006-09-05 Unilab Pharmatech, Ltd. Taste masked aqueous liquid pharmaceutical composition
US20050095299A1 (en) * 2003-10-30 2005-05-05 Wynn David W. Controlled release analgesic suspensions

Also Published As

Publication number Publication date
AR051411A1 (es) 2007-01-10
RU2395275C2 (ru) 2010-07-27
PL1809241T3 (pl) 2012-01-31
JP2008518948A (ja) 2008-06-05
KR20070085529A (ko) 2007-08-27
EP1809241A2 (de) 2007-07-25
MX2007005207A (es) 2007-11-08
WO2006050302A3 (en) 2007-02-15
CA2585852C (en) 2013-06-25
CN101068530A (zh) 2007-11-07
RU2007119722A (ru) 2008-12-10
US20060093631A1 (en) 2006-05-04
CA2585852A1 (en) 2006-05-11
WO2006050302A2 (en) 2006-05-11
KR101317657B1 (ko) 2013-10-15
EP1809241B1 (de) 2011-08-03
BRPI0517245A (pt) 2008-10-07
ES2368249T3 (es) 2011-11-15

Similar Documents

Publication Publication Date Title
DK1874273T3 (da) Gastro-resistent farmaceutiske formuleringer indeholdende rifaximin
EP1748765A4 (de) Pharmazeutische suspensionszusammensetzung
HUS1400051I1 (hu) Lurazidont tartalmazó gyógyászati készítmény
DK1957073T3 (da) Lægemiddel
EP1780139A4 (de) Behälter
DE602004031713D1 (de) Optischer Biochip
DK1757293T3 (da) Bh4-responsiv hyperphenylalaninæmi-medikamenter
DE602005002716D1 (de) Haltevorrichtung
EP1902406A4 (de) Biometrischer arzneimittelbehälter
PL1809241T3 (pl) Bezbarwna farmaceutyczna zawiesina zawierająca acetaminofen
ATE374604T1 (de) Coffein enthaltendes konfekt
ITTO20040494A1 (it) Container telonato
AT500804B8 (de) Abstandhalter
UA10405S (uk) Контейнер лабораторний
SE0402678D0 (sv) Pharmaceutical use
SE0402638D0 (sv) Pharmaceutical use
SE0402639D0 (sv) Pharmaceutical use
SE0402637D0 (sv) Pharmaceutical use
SE0400990D0 (sv) Läkemedel
FI20080129A7 (fi) Uusia farmaseuttisia yhdisteitä
ITRM20050096A1 (it) Portaciabatte adesivo.
UA12182S (uk) Етикетка медичного препарату
FI6195U1 (fi) Roskasäiliö
BRMU8402382Y8 (pt) porta-chupetas
AT500742B8 (de) Abstandhalter

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties